Home>Events>European Advance Biotech Grant Program

Biotech Start-up Symposium

Register Today

Join your colleagues at this two-day symposium and networking event designed specifically for start-up biotech companies. Hosted at Merck in Molsheim, France, speakers will be discussing topics that range from technical (oxygen transfer modelling for bioreactor scaling) to growing your company (going from an idea at a university to a clinical phase biotech) to operations (outsourcing and virtual companies).

This event will include: presentations by industry experts, moderated round table discussions, M Lab Collaboration Center tours and exceptional networking opportunities throughout the entire program.

Register Here


Day 1- Tuesday, April 21, 2020

8:00- 10:00 AM Breakfast and Registration
10:00 - 10:30 AM Welcome
Frederic Sengler & Ushma Mehta, Merck
10:30 - 11:15 AM Application of DOE based oxygen transfer modelling to improve bioreactor scale up and scale down
Dr Ronan O’Kennedy – ROK Bioconsulting
11:15 - 12:00 AM Roundtable Discussion
12:00 - 1:00 PM Lunch at M Lab® Collaboration Center
1:00 - 1:45 PM Considerations for the Development of Biologics by Virtual Companies
Jonathan Dempsey – Dempsey Consulting
1:45 - 2:30 PM Roundtable Discussion
2:30 - 3:15 PM Break and Poster Session
3:15 - 4:00 PM Faster, safer and affordable access to GMP grade Angiogenic Stem Cell for academic clinical trial
Pierre Monsan – Cell-Easy
4:00 - 4:45 PM Presentation by: 2020 Advance Biotech Grant Recipient
4:45 - 5:45 PM Transfer to Strasbourg
5:45 – 10:00 PM Evening event + 2020 Advance Biotech Grant Award Ceremony


Day 2- Wednesday, April 22, 2020

8:00- 9:00 AM Transfer from Hotel to M Lab Collaboration Center
9:00 – 9:45 AM TILT’s route from university startup to a clinical stage biotech
Aino Kalervo – Tilt Biotherapeutics
9:45 – 10:30 AM Next Generation Gene Therapy for Musculoskeletal Disorders
Kilian Guse - GeneQuine
10:30 – 11:15 AM Break and Poster Session
11:15 AM – 12:00 PM Roundtable Discussion
12:00 – 12:45 PM Financing Strategies for Emerging Biotech
Joey Mason- MVentures
12:45 – 1:45 PM Lunch
1:45 – 2:30 PM ImCheck Bring the First gd T Cell Activating Antibody to the Clinic
Pierre d’Epenoux – ImCheck Therapeutics
2:30 – 3:15 PM Ned Wakeman- BioHub Alderley Park
3:15 – 3:30 PM Closing Session

Roundtable Discussions:
  • Biotech Start-up/CDMO Partner: Setting the right level of expectation to insure project success
    • Moderator: Alain Rachon - Director Business Development Merck Biodevelopment
  • Process scale up strategies with respect to eventual tech transfer
    • Moderator: Dr Paul Beckett – Technology manager, Merck
  • Tour our brand new M Lab™ Collaboration Center
European Advance Biotech Grant Program

Program Information

Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 9th edition, is open for European* biotech companies, to help you accelerate to clinic faster.

Apply now for a chance to win bioprocessing technologies, bioprocessing process development support, and Active and Formulations technologies.

This year a single grand prize of €240,000 will be awarded in bioprocess technologies, process development support, and actives and formulations. Excludes BioReliance® services.

Please submit a completed application before March 1, 2020. Grant Winner will be announced in April 2020.

Rules & Regulations

Apply Now

  • Netherlands, Belgium, Switzerland, United Kingdom, Ireland, France, Germany, Denmark, Finland, Norway, Austria, Spain, Portugal and Sweden – see official rules for eligibility.